Latest Asx News

Cardno Limited has requested an immediate suspension from ASX quotation to facilitate its removal from the official ASX list, marking a significant step in its delisting process.

Benz Mining has completed its acquisition of the Glenburgh and Mt Egerton gold projects in Western Australia from Spartan Resources, marking a strategic expansion with Spartan becoming a significant shareholder and board participant.

Spartan Resources has completed the sale of its Glenburgh and Egerton gold projects to Benz Mining for $1 million in cash, a 15% equity stake, and potential contingent payments. This strategic move allows Spartan to sharpen its focus on its high-grade Dalgaranga Gold Project while maintaining influence through board representation at Benz.

Ingenia Communities Group has raised its FY25 EBIT and EPS guidance following a robust first half, driven by operational efficiencies and a revitalised development pipeline.

PWR Holdings' North American arm, C&R Racing Inc., has landed a $8.9 million AUD order to supply advanced cooling systems for a US government aerospace project, marking a pivotal milestone in its defence sector expansion.

Nordic Resources has secured three additional exploration licences at its Pulju nickel-copper-cobalt project in Finland, expanding its granted tenure to 46 square kilometres and consolidating 12 kilometres of continuous strike within a key mineralised formation. This strategic move enhances the company’s potential to develop a significant European critical metals resource.

Advance ZincTek reports steady profit before tax for H1 FY25, driven by strong North American growth and significant cost savings following its Perth facility closure.

HITIQ Limited has received $1.6 million from the R&D Tax Incentive Scheme, using most of it to repay its RDTI Facility with Keystone Capital Partners, signaling a strategic move to streamline its R&D funding.

First Graphene Limited has responded to an ASX price query, attributing its recent share price and volume surge to increased buying activity in Germany linked to prior commercial announcements, while reaffirming full compliance with ASX disclosure rules.

Nex Metals Explorations has repriced and partially completed its capital raise, securing $1.06 million at a reduced share price to fund development and exploration activities.

Immuron has submitted its Phase 2 clinical study report for Travelan® to the FDA, revealing statistically significant immunological and microbiome benefits. The company is preparing to engage the FDA for Phase 3 trial discussions while progressing a large field study with military personnel.

Vonex Limited has vested performance rights for its CEO and directors following MaxoTel’s acquisition of majority control, with shares set to be sold on-market. The company reports a mixed 1H FY25 financial performance and is exploring options to repay a $23 million debt facility, including a potential capital raise.